BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
322.90
-8.50 (-2.56%)
At close: Dec 5, 2025, 4:00 PM EST
322.40
-0.50 (-0.15%)
After-hours: Dec 5, 2025, 7:07 PM EST
BeOne Medicines AG Employees
BeOne Medicines AG had 11,000 employees as of December 31, 2024. The number of employees increased by 400 or 3.77% compared to the previous year.
Employees
11,000
Change (1Y)
400
Growth (1Y)
3.77%
Revenue / Employee
$452,062
Profits / Employee
$6,232
Market Cap
35.73B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ONC News
- 2 days ago - BeOne Medicines Continues To Execute In Q3 - Seeking Alpha
- 10 days ago - Artisan International Small-Mid Fund Q3 2025 Performance Review - Seeking Alpha
- 10 days ago - U.S. FDA Grants Priority Review to Sonrotoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma - Business Wire
- 16 days ago - BeOne Medicines Showcases Leadership in B-cell Malignancies at ASH 2025 - Business Wire
- 19 days ago - BeOne Medicines AG (ONC) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 19 days ago - Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma - Business Wire
- 25 days ago - BeOne Medicines AG (ONC) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript - Seeking Alpha
- 4 weeks ago - BeOne Medicines AG (ONC) Q3 2025 Earnings Call Transcript - Seeking Alpha